August_Industry Review|Poly M&A Strategy Series(Chinese)
Porui's M&A Financing Strategy: Creating a King of M&A Profitability and Prying Taiwan's CDMO Strategy into Opportunity Growth
An analysis of Porui's M&A financing strategy reveals that, as shown in Figure 2, Porui's M&A financing is based on the following four approaches: syndicated loans, convertible bonds, free capital, and stock exchange strategies, such as "borrowing and syndication" or joining hands with a private equity fund to invest; issuing convertible bonds; free capital or retained earnings of the company; and a value-based stock exchange, etc., in order to raise M&A start-up capital and repay a portion of the acquisition capital through the expected future revenues of the target company. A portion of the acquisition proceeds will be repaid on a yearly basis through the expected future revenue of the target company. 圖2. 保瑞併購融資策略 Source: Organized by Ji-Pu Industrial Trend Research Institute. 以安成藥業併購為例,收購案60億台幣,保瑞透過聯貸,如與聯貸銀行團(中國信託)簽訂40億元台幣之5年期聯合授信合約(備註: 在財報反映出因併購需求動撥聯貸,使得借款餘額增加,增加相關財務費用(利息支出)、可轉換債CB、及公司自由資金,籌得併購總資金。其中先付六成資金(約36億元)給被收購公司經營者(股東),另4成(約24億元)作為綁定被收購公司未來業績,透過未來3年安成的營收分潤來支付,創造併購標的帶來營收與獲利模式。在併購美國Upsher-Smith製藥公司也是以類似併購安成藥業籌資方案進行,其中強化財務管控的負債比、股本擴張、拆借還款、利息支出和公司淨值,以及被收購公司的穩定持續獲利就顯得更為重要,也造就保瑞取得併購獲利王的美譽,讓5年內營收成長大翻5倍,2023年營收達141.95億,並持續往營收挑戰200億大關邁進。 -For more information, please contact us at





